evaluation of the patient with dementia

39
EVALUATION OF THE PATIENT WITH DEMENTIA Jonathan T. Stewart, MD Professor in Psychiatry University of South Florida College of Medicine Chief, Geropsychiatry Section Bay Pines VA Medical Center

Upload: marina761

Post on 26-Jun-2015

1.080 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Evaluation of the Patient with Dementia

EVALUATION OF THE PATIENT WITH DEMENTIA

Jonathan T. Stewart, MDProfessor in Psychiatry

University of South Florida College of Medicine

Chief, Geropsychiatry Section

Bay Pines VA Medical Center

Page 2: Evaluation of the Patient with Dementia

DEMENTIA

A syndrome characterized by acquired, progressive cognitive impairment

Affects 10% of individuals over 65 Caused by at least 80 different diseases, many

reversible Unfortunately, the most common diseases (85 – 90%)

are irreversible Diagnosis will have prognostic and treatment

implications All demented patients need a work-up

…and it’s mostly a good history

Page 3: Evaluation of the Patient with Dementia

PRIMARY SYMPTOMS

ATTENTION MEMORY POSTROLANDIC (“COGNITION”) EXECUTIVE (FRONTAL/SUBCORTICAL) INSIGHT

Page 4: Evaluation of the Patient with Dementia

PRIMARY SYMPTOMS

ATTENTION: clouded sensorium, delirium MEMORY: forgetfulness POSTROLANDIC: aphasia, apraxia, getting

lost EXECUTIVE: poor judgment, disinhibition,

abulia, urge incontinence INSIGHT: anosognosia, catastrophic

reactions

Page 5: Evaluation of the Patient with Dementia

TWO TYPES OF DEMENTIA

Postrolandic Frontal/subcortical

Page 6: Evaluation of the Patient with Dementia

POSTROLANDIC

Memory deficits Aphasia Apraxia Agnosia Personality more or

less preserved MMSE valid

FRONTAL/SUBCORTICAL

Memory deficits Loss of behavioral plasticity

and adaptability, judgment Personality changes

Disinhibition Abulia

Urge incontinence MMSE useless

Page 7: Evaluation of the Patient with Dementia

THE REST OF THE HISTORY

Time course Depressive symptoms Past medical history

Medical and psychiatric conditionsFamily HxEtOHMedications (including OTC, OPM)

Page 8: Evaluation of the Patient with Dementia

THE REST OF THE EXAM

Physical exam Neurologic exam Mental status exam

Page 9: Evaluation of the Patient with Dementia

THE FOLSTEIN MMSE

Most studied and used of the standardized exams

Quick and easy to administer Excellent inter-rater reliability Accurately measures the severity and

progression of Alzheimer’s disease Does not detect executive deficits at all

Page 10: Evaluation of the Patient with Dementia

BEYOND THE MMSE

ATTENTION: digit span or “DLROW” MEMORY: 3 word recall, orientation POSTROLANDIC: naming, praxis,

calculations, intersecting pentagons EXECUTIVE: contrasting programs,

Luria figures, go-no go, controlled word fluency, frontal release signs

Page 11: Evaluation of the Patient with Dementia

LURIA’S RECURSIVE FIGURES

Page 12: Evaluation of the Patient with Dementia

LURIA’S RECURSIVE FIGURES

Page 13: Evaluation of the Patient with Dementia

LURIA’S RECURSIVE FIGURES

Page 14: Evaluation of the Patient with Dementia

THE GERIATRIC DEPRESSION SCALE (GDS)

Good screen for most patients Easy to administer and score Face-valid, so patients can “fake good”

or “fake bad” Valid for demented patients with an

MMSE above about 12Use DMAS or Cornell scale for severely

demented patients

Page 15: Evaluation of the Patient with Dementia

THE REST OF THE WORK-UP

Basic labs Thyroid function tests B12 (methylmalonic acid and homocysteine

if borderline) Serology HIV, drug screen, others, as indicated Neuroimaging study, usually LP or EEG, rarely

Page 16: Evaluation of the Patient with Dementia

PLEASANT SURPRISES

Depression Iatrogenic (anticholinergics, sedatives, narcotics, H2

blockers, multiple meds) Hypothyroidism B12 deficiency Neurosyphilis Alcoholic dementia Normal pressure hydrocephalus Subdural hematoma Others

Page 17: Evaluation of the Patient with Dementia

POSTROLANDIC DEMENTIAS

Alzheimer’s disease Diffuse Lewy body disease

Page 18: Evaluation of the Patient with Dementia

ALZHEIMER’S DISEASE

Slowly, insidiously progressive postrolandic dementia; executive sx’s much later

Neurologic exam, labs, neuroimaging studies unremarkable

Often familial, especially in younger patients

Page 19: Evaluation of the Patient with Dementia

ANTI-DEMENTIA DRUGS

May improve cognitive function, ADL’s to a modest extent; often ineffective Dechallenge if no meaningful benefit

Possibly delay nursing home placement Cholinesterase inhibitors may cause nausea,

diarrhea, weight loss Memantine occasionally causes agitation THESE AGENTS DO NOT SLOW THE

RATE OF DECLINE

Page 20: Evaluation of the Patient with Dementia

A TYPICAL STUDY

Page 21: Evaluation of the Patient with Dementia

BEWARE!

Page 22: Evaluation of the Patient with Dementia

DIFFUSE LEWY BODY DISEASE

Second most common dementia in autopsy studies

Characterized by Lewy bodies throughout the cortex

Non-familial 2:1 male:female ratio

Page 23: Evaluation of the Patient with Dementia

CLINICAL FEATURES

Postrolandic dementia More rapidly progressive than AD Fluctuation, episodes of “pseudodelirium” common

Mild parkinsonism Tremor often absent Poor response to antiparkinsonian meds Shy-Drager sx’s common

Prominent psychotic sx’s, esp visual hallucinations SEVERE NEUROLEPTIC INTOLERANCE

Page 24: Evaluation of the Patient with Dementia

FRONTAL/SUBCORTICAL DEMENTIAS

Vascular dementia Frontotemporal dementia and Pick’s disease Alcoholic dementia Huntington’s disease, Wilson’s disease, progressive

supranuclear palsy, late Parkinson’s disease AIDS dementia complex, neurosyphilis, Lyme disease Normal pressure hydrocephalus Most head injuries Anoxia, carbon monoxide Multiple sclerosis Tumors ANY ADVANCED DEMENTIA

Page 25: Evaluation of the Patient with Dementia

TYPES OF VASCULAR DEMENTIA

Multi-infarct dementia Small vessel disease

Lacunar state (gray > white)

Binswanger’s disease (white)

Hemorrhagic vascular dementia Strategic infarct dementia Dementia due to hypoperfusion

Page 26: Evaluation of the Patient with Dementia

SMALL VESSEL DISEASE

At least 50% of all vascular dementia Often coexists with MID Usual vascular risk factors, especially

HPT Steady, not step-wise deterioration Relatively more abulia than disinhibition

Page 27: Evaluation of the Patient with Dementia

FRONTOTEMPORAL DEMENTIA

Relatively uncommon, non-familial illness

Prominent (macroscopic) atrophy of frontal and anterior temporal cortex

Symptoms include executive deficits, Klüver-Bucy syndrome

About 25% of pts have Pick bodies

Page 28: Evaluation of the Patient with Dementia

MANAGEMENT

Page 29: Evaluation of the Patient with Dementia

BEHAVIORAL PROBLEMS IN DEMENTIA

Present in 80% of cases Major source of caregiver stress,

institutionalization Common at all stages of the disease Much more treatable than the

underlying dementia Poorly described in the literature

Page 30: Evaluation of the Patient with Dementia

WOOF.

MEDS OTHER

Page 31: Evaluation of the Patient with Dementia

THREE BASIC PRINCIPLES

Simplicity Limited goals The “no-fail” environment

Page 32: Evaluation of the Patient with Dementia

“THE CUSTOMER IS ALWAYS

RIGHT!”

Page 33: Evaluation of the Patient with Dementia

DEPRESSION

20-30% incidence in Alzheimer’s disease, often early in the course of the illness

Most important treatable cause of excess disability

Responds very well to treatment

Page 34: Evaluation of the Patient with Dementia

ACUTE BEHAVIOR CHANGE

I atrogenic I nfection I llness I njury I mpaction I nconsistency I s the patient depressed?

Page 35: Evaluation of the Patient with Dementia

AGITATION

Present in up to 80% of patients Up to 34% of patients are combative Few predictors Probably a very heterogeneous problem Cornerstone of treatment is

nonpharmacologic

Page 36: Evaluation of the Patient with Dementia

EMPIRICALLY EFFECTIVE MEDS FOR AGITATION

Atypical neuroleptics (best when agitation is clearly related to delusions or hallucinations)

Anticonvulsants Trazodone Beta-blockers Buspirone Benzodiazepines Others

Page 37: Evaluation of the Patient with Dementia

THE BEST NUMBER OF MEDICATIONS TO USE IS

ZERO (or sometimes one)

WHEN IN DOUBT, GET RID OF MEDICATIONS!

Page 38: Evaluation of the Patient with Dementia

DON’T FORGET SAFETY ISSUES!

DRIVING FIREARMS POWER TOOLS SMOKING IN BED POISONS, MEDICATIONS FALL RISK

Page 39: Evaluation of the Patient with Dementia

WOOF!

MEDS OTHER

GOOD LUCK!